Skip to Content
  1. All Products
  2. Biosimilar Antibodies
  3. Gentaur Epcoritamab – Anti-CD3E / CD20 (MS4A1) Bispecific
-
Gentaur Epcoritamab – Anti-CD3E / CD20 (MS4A1) Bispecific

Gentaur Epcoritamab – Anti-CD3E / CD20 (MS4A1) Bispecific

https://bio.gentaur.us/web/image/product.template/26257/image_1920?unique=58978df
(0 review)
Bridges T-cells to B-cells by binding CD3E and CD20, driving targeted B-cell depletion. Ideal for lymphoma and immunotherapy models.

1,234,567.00 € 1234567.0 EUR 1,234,567.00 € Tax Excluded

1,234,567.00 € Tax Excluded

Not Available For Sale

(0.00 € / Units)

This combination does not exist.

This content will be shared across all product pages.

Contact Us

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days

Share

Internal Reference: GMA-CD3E
Website URL: /shop/gma-cd3e-gentaur-epcoritamab-anti-cd3e-cd20-ms4a1-bispecific-26257
Display Name: [GMA-CD3E] Gentaur Epcoritamab – Anti-CD3E / CD20 (MS4A1) Bispecific

Your Dynamic Snippet will be displayed here... This message is displayed because you did not provided both a filter and a template to use.